Nipecotic Acidum CAS 498-95-3

Description:

Chemical Name: Nipecotic Acidum

CAS: 498-95-3

Aspectus: alba vel flavescens Crystallina pulveris

Dic: ≥98.0% (TLC)

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum Nipecoticum acidum
Synonyma DL-Nipecotic Acidum;3-Piperidine carboxylic Acidum;H-DL-Nip-OH
CAS Number 498-95-3
CATTUS Number RF-PI284
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C6H11NO2
M. Pondus 129.16
Aqua Solubility Solutum in aqua
Shipping Condition Uit sub Ambient Temperature
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Crystallinum album aut flavescens;
Decompose Temperature ≥261.0℃
Lepidium sativum IR, NMR
Damnum in Siccatio ≤1.0%
Residere in Ignition ≤1.0%
Asssay / Analysis Methodo ≥98.0% (TLC)
Test Standard Enterprise Latin;Pharmacopoeia Sinica (CP)
Consuetudinem Pharmaceutical intermedia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard Drum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.

commoda:

1

FAQ:

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarium fabricae et supplementi acidi Nipecotici (CAS: 498-95-3) cum qualitate, late in synthesi organica, synthesi intermediorum pharmaceuticae et synthesis pharmaceuticae activae.Acidum nipecoticum (CAS: 498-95-3) est inhibitor potentiale susceptionis acidi γ-aminobutyrici (GABA) in pecias cerebri rat.Derivationes lipophilicae acidi nipecotici pro medicamentis ad epilepsiam curationem adhibentur.
Applicationem
Acidum nipecoticum adhibitum est in determinatione medicamentorum antiepileticorum vigabatrini et amino acido neurotransmittentes in rat cerebri extracellulares fluidi capillares;electrophoresis cum detectione laser-educta fluorescens;Reactant ad esterificationem concurrentem et N-acteylationem amino acida cum orthoesters
Reactant ad summam;
Anticonvulsants:HCV NS5B polymerase inhibitores;Cathepsin S inhibitores;Antiagonistae pro inhibitione aggregationis plateleletanae oretenus P2Y12;modulator allostericus receptor metabotropici glutamatis positivus 4

Epistulam tuam hic scribe et mitte nobis